AstraZeneca Pharmaceuticals Q1 2026 supplier risk profile: 88 shipments, 7 suppliers, B-grade assessment.
AstraZeneca Pharmaceuticals imported 88 shipments in Q1 2026 across 7 suppliers located in 7 countries. France dominates the sourcing footprint, accounting for 73% of shipments, primarily through AstraZeneca Dunkerque Production which supplied 64 shipments. The majority of imports fall under HS chapter 30 (pharmaceutical products), with HS code 300432 representing 72% of total shipment volume. Secondary suppliers include AstraZeneca entities in Sweden and the UK, along with specialty chemical and equipment providers in Belgium, Germany, and China.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
No sanctions watchlist matches were detected for AstraZeneca Pharmaceuticals during Q1 2026. No suppliers registered forced-labor exposure under UFLPA proximity criteria.
7 distinct tier-1 suppliers in Q1 2026
| ASTRAZENECA DUNKERQUE PRODUCTION | France | 64 |
| ASTRAZENECA | Sweden | 11 |
| ASTRAZENECA UK | United Kingdom | 8 |
| AJINOMOTO OMNICHEM | Belgium | 2 |
| HANGZHOU COBETTER FILTRATION EQUIPM | China | 1 |
| HS LUFTFILTERBAU | Germany | 1 |
| YPSOMED | Switzerland | 1 |
Share of Q1 2026 inbound shipments by source country
21 tier-2 + 131 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.